Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons

Jason D. Robarge, Djane B. Duarte, Behzad Shariati, Ruizhong Wang, David A. Flockhart, Michael Vasko

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Although aromatase inhibitors (AIs) are commonly used therapies for breast cancer, their use is limited because they produce arthralgia in a large number of patients. To determine whether AIs produce hypersensitivity in animal models of pain, we examined the effects of the AI, letrozole, on mechanical, thermal, and chemical sensitivity in rats. In ovariectomized (OVX) rats, administering a single dose of 1 or 5 mg/kg letrozole significantly reduced mechanical paw withdrawal thresholds, without altering thermal sensitivity. Repeated injection of 5 mg/kg letrozole in male rats produced mechanical, but not thermal, hypersensitivity that extinguished when drug dosing was stopped. A single dose of 5 mg/kg letrozole or daily dosing of letrozole or exemestane in male rats also augmented flinching behavior induced by intraplantar injection of 1000 nmol of adenosine 5'-triphosphate (ATP). To determine whether sensitization of sensory neurons contributed to AI-induced hypersensitivity, we evaluated the excitability of neurons isolated from dorsal root ganglia of male rats chronically treated with letrozole. Both small and medium-diameter sensory neurons isolated from letrozole-treated rats were more excitable, as reflected by increased action potential firing in response to a ramp of depolarizing current, a lower resting membrane potential, and a lower rheobase. However, systemic letrozole treatment did not augment the stimulus-evoked release of the neuropeptide calcitonin gene-related peptide (CGRP) from spinal cord slices, suggesting that the enhanced nociceptive responses were not secondary to an increase in peptide release from sensory endings in the spinal cord. These results provide the first evidence that AIs modulate the excitability of sensory neurons, which may be a primary mechanism for the effect of these drugs to augment pain behaviors in rats.

Original languageEnglish (US)
Pages (from-to)53-65
Number of pages13
JournalExperimental Neurology
Volume281
DOIs
StatePublished - Jul 1 2016

Fingerprint

letrozole
Aromatase Inhibitors
Sensory Receptor Cells
Hypersensitivity
exemestane
Hot Temperature
Spinal Cord
Pain
Architectural Accessibility
Injections
Calcitonin Gene-Related Peptide
Arthralgia
Spinal Ganglia
Neuropeptides
Pharmaceutical Preparations

Keywords

  • Aromatase inhibitors
  • Calcitonin gene-related peptide
  • Electrophysiology
  • Excitability
  • Exemestane
  • Hypersensitivity
  • Letrozole
  • Nociception
  • Pain
  • Sensory neuron

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons. / Robarge, Jason D.; Duarte, Djane B.; Shariati, Behzad; Wang, Ruizhong; Flockhart, David A.; Vasko, Michael.

In: Experimental Neurology, Vol. 281, 01.07.2016, p. 53-65.

Research output: Contribution to journalArticle

Robarge, Jason D. ; Duarte, Djane B. ; Shariati, Behzad ; Wang, Ruizhong ; Flockhart, David A. ; Vasko, Michael. / Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons. In: Experimental Neurology. 2016 ; Vol. 281. pp. 53-65.
@article{7340ae3eb8ac4369a9551e8a3e6dd868,
title = "Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons",
abstract = "Although aromatase inhibitors (AIs) are commonly used therapies for breast cancer, their use is limited because they produce arthralgia in a large number of patients. To determine whether AIs produce hypersensitivity in animal models of pain, we examined the effects of the AI, letrozole, on mechanical, thermal, and chemical sensitivity in rats. In ovariectomized (OVX) rats, administering a single dose of 1 or 5 mg/kg letrozole significantly reduced mechanical paw withdrawal thresholds, without altering thermal sensitivity. Repeated injection of 5 mg/kg letrozole in male rats produced mechanical, but not thermal, hypersensitivity that extinguished when drug dosing was stopped. A single dose of 5 mg/kg letrozole or daily dosing of letrozole or exemestane in male rats also augmented flinching behavior induced by intraplantar injection of 1000 nmol of adenosine 5'-triphosphate (ATP). To determine whether sensitization of sensory neurons contributed to AI-induced hypersensitivity, we evaluated the excitability of neurons isolated from dorsal root ganglia of male rats chronically treated with letrozole. Both small and medium-diameter sensory neurons isolated from letrozole-treated rats were more excitable, as reflected by increased action potential firing in response to a ramp of depolarizing current, a lower resting membrane potential, and a lower rheobase. However, systemic letrozole treatment did not augment the stimulus-evoked release of the neuropeptide calcitonin gene-related peptide (CGRP) from spinal cord slices, suggesting that the enhanced nociceptive responses were not secondary to an increase in peptide release from sensory endings in the spinal cord. These results provide the first evidence that AIs modulate the excitability of sensory neurons, which may be a primary mechanism for the effect of these drugs to augment pain behaviors in rats.",
keywords = "Aromatase inhibitors, Calcitonin gene-related peptide, Electrophysiology, Excitability, Exemestane, Hypersensitivity, Letrozole, Nociception, Pain, Sensory neuron",
author = "Robarge, {Jason D.} and Duarte, {Djane B.} and Behzad Shariati and Ruizhong Wang and Flockhart, {David A.} and Michael Vasko",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.expneurol.2016.04.006",
language = "English (US)",
volume = "281",
pages = "53--65",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons

AU - Robarge, Jason D.

AU - Duarte, Djane B.

AU - Shariati, Behzad

AU - Wang, Ruizhong

AU - Flockhart, David A.

AU - Vasko, Michael

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Although aromatase inhibitors (AIs) are commonly used therapies for breast cancer, their use is limited because they produce arthralgia in a large number of patients. To determine whether AIs produce hypersensitivity in animal models of pain, we examined the effects of the AI, letrozole, on mechanical, thermal, and chemical sensitivity in rats. In ovariectomized (OVX) rats, administering a single dose of 1 or 5 mg/kg letrozole significantly reduced mechanical paw withdrawal thresholds, without altering thermal sensitivity. Repeated injection of 5 mg/kg letrozole in male rats produced mechanical, but not thermal, hypersensitivity that extinguished when drug dosing was stopped. A single dose of 5 mg/kg letrozole or daily dosing of letrozole or exemestane in male rats also augmented flinching behavior induced by intraplantar injection of 1000 nmol of adenosine 5'-triphosphate (ATP). To determine whether sensitization of sensory neurons contributed to AI-induced hypersensitivity, we evaluated the excitability of neurons isolated from dorsal root ganglia of male rats chronically treated with letrozole. Both small and medium-diameter sensory neurons isolated from letrozole-treated rats were more excitable, as reflected by increased action potential firing in response to a ramp of depolarizing current, a lower resting membrane potential, and a lower rheobase. However, systemic letrozole treatment did not augment the stimulus-evoked release of the neuropeptide calcitonin gene-related peptide (CGRP) from spinal cord slices, suggesting that the enhanced nociceptive responses were not secondary to an increase in peptide release from sensory endings in the spinal cord. These results provide the first evidence that AIs modulate the excitability of sensory neurons, which may be a primary mechanism for the effect of these drugs to augment pain behaviors in rats.

AB - Although aromatase inhibitors (AIs) are commonly used therapies for breast cancer, their use is limited because they produce arthralgia in a large number of patients. To determine whether AIs produce hypersensitivity in animal models of pain, we examined the effects of the AI, letrozole, on mechanical, thermal, and chemical sensitivity in rats. In ovariectomized (OVX) rats, administering a single dose of 1 or 5 mg/kg letrozole significantly reduced mechanical paw withdrawal thresholds, without altering thermal sensitivity. Repeated injection of 5 mg/kg letrozole in male rats produced mechanical, but not thermal, hypersensitivity that extinguished when drug dosing was stopped. A single dose of 5 mg/kg letrozole or daily dosing of letrozole or exemestane in male rats also augmented flinching behavior induced by intraplantar injection of 1000 nmol of adenosine 5'-triphosphate (ATP). To determine whether sensitization of sensory neurons contributed to AI-induced hypersensitivity, we evaluated the excitability of neurons isolated from dorsal root ganglia of male rats chronically treated with letrozole. Both small and medium-diameter sensory neurons isolated from letrozole-treated rats were more excitable, as reflected by increased action potential firing in response to a ramp of depolarizing current, a lower resting membrane potential, and a lower rheobase. However, systemic letrozole treatment did not augment the stimulus-evoked release of the neuropeptide calcitonin gene-related peptide (CGRP) from spinal cord slices, suggesting that the enhanced nociceptive responses were not secondary to an increase in peptide release from sensory endings in the spinal cord. These results provide the first evidence that AIs modulate the excitability of sensory neurons, which may be a primary mechanism for the effect of these drugs to augment pain behaviors in rats.

KW - Aromatase inhibitors

KW - Calcitonin gene-related peptide

KW - Electrophysiology

KW - Excitability

KW - Exemestane

KW - Hypersensitivity

KW - Letrozole

KW - Nociception

KW - Pain

KW - Sensory neuron

UR - http://www.scopus.com/inward/record.url?scp=84964453406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964453406&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2016.04.006

DO - 10.1016/j.expneurol.2016.04.006

M3 - Article

C2 - 27072527

AN - SCOPUS:84964453406

VL - 281

SP - 53

EP - 65

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -